Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences DXS Track Two

DXS Track Two Agenda

Other Track Agendas

DXS Track One | DXS Track Two | 

Print Agenda

Thursday, 13 October 2016


Registration & Coffee


Opening Welcome by Lim Chuan Poh, Chairman, A*STAR in the Main Room


Plenary Session in the Main Room


Coffee Break and Networking in Exhibition Area

Cancer Diagnostics


Patrick TanKeynote Presentation

Genomic Determinants of Clinical Behaviour in Solid Tumors– Emerging Challenges for Liquid Biopsies
Patrick Tan, Professor, Duke-NUS Medical School and Deputy Executive Director, Biomedical Research Council, A*STAR, Singapore


The Promise of Liquid Biopsies Across the Continuum of Cancer Care
Sarah Ng, Post-doctoral Fellow , IMCB, Singapore


A Feasibility Study to Detect PD-L1 and PD-L2 on the Surface of Circulating Tumor Cells Using Microfluic-Based Chipcytometry
Jinkai Teo, Scientist, Merck, Singapore


Unveiling the Circulating Tumor-endothelial Cell Cluster
Min-Han Tan, Team Leader, Principal Research Scientist, Institute Of Bioengineering & Nanotechnology A*Star, Singapore


BioDot IncTechnology Spotlight:
Real Time Dispensing Quality Control for R&D and Production
Jeff Chen, Sales Director of SE Asia and Korea, BioDot Inc


Lunch, Poster Session and Networking in Exhibit Hall

Next-Generation Sequencing (NGS) for Liquid Biopsy Development and Companion Diagnostics


Roger FooKeynote Presentation

The Application of Clinical Genomics for Rare Diseases
Roger Foo, Group Leader, GIS, Singapore


An Exploration on how Sequencing of Circulating Cell-free RNA in Plasma are Enabling RNA-based Molecules as Clinical Biomarkers
Winston Koh, Scientist, Stanford University, United States of America


Next-generation sequencing as a tool for non-invasive prenatal testing for single gene disorders and aneuploidy
Angela Barrett, Research Fellow, National University of Singapore, Singapore


The Promise of Liquid Biopsies to Precision Medicine
Richie Soong, Senior Principle Investigator, National University of Singapore, Singapore


Coffee Break and Networking in Exhibition Hall

Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development


Mahesh ChoolaniKeynote Presentation

Intraoperative Diagnostic Biomarker for Ovarian Cancer
Mahesh Choolani, Research Director , National University Health System (NUHS), Singapore


Molecular Characterization of Circulating Tumor Cells Defines Genetic Signatures for Individualized Cancer Care
Say Li Kong, Research Associate, Genome Institute of Singapore, Singapore


A Novel Blood-based, Host Response Gene Expression Signature for Early Sepsis
Siew Hwa Ong, CEO, Acumen Research Laboratories, Singapore


Hospital-integrated Biobank as an Infrastructure Boosting Diagnostics Discovery and Development
Olli Carpen , Professor of Pathology, Scientific Director , University of Helsinki & Helsinki Biobank, Finland


Drinks Reception & Canapes in the Exhibition Hall


End of Day One

Friday, 14 October 2016


Registration & Coffee

Plenary Session


Jean-Luc  ButelPlenary Presentation

Diagnostics Ecosystems in Asia Pacific
Jean-Luc Butel, Global Healthcare Advisor, President, K8 Global & Senior Advisor , McKinsey&Company, Singapore


Steven  Myint Plenary Presentation

Funding Landscape in Asia
Steven Myint , Senior fellow, Consultant, Adjunct Professor, Chairman, ETPL, Duke-NUS, Inex Private Ltd, Singapore


Coffee Break and Networking in Exhibition Area

Asia/Pacific vs EU vs US Regulatory Landscape and Barriers to Entry


John CW  LimKeynote Presentation

Regulatory Systems Innovation in the Asia Pacific
John CW Lim, Executive Director, Centre of Regulatory Excellence, Duke-NUS Medical School Singapore, Deputy Director of Medical Services (Industry & Research Matters) , Ministry of Health, Singapore


Parallels to Developed Markets as China and Asia Move Forward
Nat Whitney, President, Whitney Research, Inc, China


Europe & USA Medical Device Regulatory Updates
Hwee Ee Tan, Principal Consultant/Director, DH RegSys Pte Ltd, Singapore


Lunch Break and Networking in Exhibition Area

Novel Diagnostic Tools Session


David WongKeynote Presentation

EFIRM Liquid Biopsy
David Wong, Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles, United States of America


Development of Blood Based microRNA Tests for Early Detection of Gastric and Breast Cancer
Lihan Zhou, Co Founder/Chief Technology Officer, MiRXES Pte Ltd, Singapore


An Improved Method for Sensitive and High-throughput Quantification of cfDNA in Liquid Biopsy using the Clarity Tube-strip Digital PCR
Johnson Ng, Founder And CEO, JN Medsys Pte Ltd, Singapore


Nicca Chemical Co.,Ltd.Technology Spotlight:
Ultrafast Reversible DNA Photo Cross-Linker 3-Cyanovinylcarbazole Modified Nucleosides from Nicca
Takahiro Inatsugi, Assistant Director, Specialty Chemicals Division, Nicca Chemical Co.,Ltd.


Drinks Reception and Canapes in the Exhibition Area

Distinguished Technopreneur Speaker Forum
Session SponsorsSession Sponsor


Welcome Address by Philip Lim, CE0, ETPL


Award LogoPresentation of DTS Award by Guest of Honour, Lim Chuan Poh, A*STAR Chairman

The DTS Series was launched in 2008 as part of A*STAR’s initiatives to seed innovation and entrepreneurship in Singapore. The DTS Forum aims to engage the local research and enterprise community – including entrepreneurs, industry professionals, researchers, scholars or students – and inspire them to explore the potential of enterprise based on innovative technologies. Click here for past news on DTS.


Rudi PauwelsPlenary Presentation

The Entrepreneurial Journey: Balancing Technological Exploration and Exploitation in the Pursuit of Breakthroughs in Medicine & Healthcare
Rudi Pauwels, Founder Director/Chief Executive Officer, Biocartis, Belgium


In Conversation with DTS - Discussion Forum - Moderator: Steve Myint , Senior Fellow , A*STAR, Singapore


Networking and Refreshment

Add to Calendar ▼2016-10-13 00:00:002016-10-14 00:00:00Europe/LondonDXS Track